Neurogene (NGNE) Selling, General & Administrative (2013 - 2026)
Neurogene's Selling, General & Administrative was $11.2 million in Q2 2026, up 66.8% from $6.72 million a year earlier and up 36.6% from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Selling, General & Administrative (2013 - 2026) Analysis & Trends
On a trailing twelve-month basis, Neurogene's Selling, General & Administrative was $32.85 million through Jun 30, 2026, up 22.0% year-over-year; for FY2025, it was $28.32 million, up 25.2% from FY2024.
- Selling, General & Administrative has now increased for three consecutive years, with a five-year compound annual growth rate of 10.5% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $22.61 million in FY2024 (+102.1%), $11.19 million in FY2023 (+24.2%), $9.01 million in FY2022 (-58.2%) and $21.54 million in FY2021 (+25.1%).
- The Q2 2026 figure marks the highest quarterly Selling, General & Administrative in data going back to Q1 2013.
- Compared with a year earlier, Selling, General & Administrative has increased for ten straight quarters, with growth averaging 47.2% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q4 2024 (growth of 141.9%); the worst was Q2 2023 (a decline of 53.7%).
- Per Business Quant data, NGNE's Selling, General & Administrative in the three quarters before Q2 2026 was $8.2 million (Q1 2026), $6.89 million (Q4 2025) and $6.56 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Neurogene | 578.46 Mn | 578.46 Mn | - | 11.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.20 Mn |
| Mar 31, 2026 | 8.20 Mn |
| Dec 31, 2025 | 6.89 Mn |
| Sep 30, 2025 | 6.56 Mn |
| Jun 30, 2025 | 6.72 Mn |
| Mar 31, 2025 | 8.16 Mn |
| Dec 31, 2024 | 6.17 Mn |
| Sep 30, 2024 | 5.90 Mn |
| Jun 30, 2024 | 5.32 Mn |
| Mar 31, 2024 | 5.24 Mn |
| Dec 31, 2023 | 2.55 Mn |
| Sep 30, 2023 | 3.61 Mn |
| Jun 30, 2023 | 2.28 Mn |
| Mar 31, 2023 | 2.75 Mn |
| Dec 31, 2022 | -4.71 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 4.92 Mn |
| Mar 31, 2022 | 4.66 Mn |
| Dec 31, 2021 | 5.41 Mn |
| Sep 30, 2021 | 5.56 Mn |
API Access
Neurogene Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();